drugset / Trial / NCT02066077

The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy

NCT02066077

RandomizedParallel-groupTriple-blindTreatment

Summary

1. To determine the influencing factors of modified electroconvulsive therapy (MECT); 2. To determine the influencing factors and reversibility of the cognitive impairment caused by MECT; 3. To determine the duration of efficacy of MECT and its affecting factors.

Timeline

Start
2013-01-01
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Etomidate Small molecule 0.3 mg/kg
Background Propofol Small molecule 2 mg/kg